Hvivo

HVO · AIM · Health Care · mcap £41m · 6.0p

Beta Briefing, track record and bull & bear case are not ready for Hvivo yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 54 companies are already wired into a briefing: browse them.

Octopus Investments Limited 27 Oct – 8 Sep · 7 notices

14.1% → 14.0%

share price at the notices 6.7–8.9p · now 6.0p 27 Oct 2025 11 Feb 2026 16 Feb 2026 26 Mar 2026 12 May 2026 9 Jun 2026 8 Sep 2026

Rathbones Investment Management Ltd 6 Nov – 27 Feb · 2 notices

12.0% → 10.0%

share price at the notices 6.5–8.5p · now 6.0p 6 Nov 2025 27 Feb 2026

Directors

No open-market share purchases by directors in 12 months.

other hVIVO plc has appointed Richard Cotton as an Independent Non-Executive Director, effective immediately, who will also chair the Audit Committee. Cotton brings extensive financial and life sciences board-level experience, 18 Dec 2025

sale Brendan Buckley, a Non-Executive Director of hVIVO plc, has sold 2,017,000 ordinary shares at 8.65p per share, totaling £174,470.50. Following this transaction, Mr. Buckley now holds 2,000,270 ordinary shares and has ind 24 Apr 2026

award hVIVO plc announced board changes effective October 1, 2026, with the appointment of Caroline Shaw, CBE as Independent Non-Executive Director and Chair of the Remuneration Committee, and the stepping down of Elaine Sulli 22 Sep 2026

Company filings. Not investment advice.